Critical Control Point Model In PAT Guidance Supported By Industry
This article was originally published in The Tan Sheet
Executive Summary
FDA should adopt a critical control point model requiring firms only maintain data that pertain to significant manufacturing stages when drafting its Process Analytical Technology guidance, industry reps suggest